Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027183 · ClinicalTrials.gov registry record
Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 134
- Enrollment target
NCT00027183 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 134 participants.
The verdict
NCT00027183 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
Some bacteria that cause disease can produce toxic substances that may worsen the disease. Pseudomonas aeruginosa is a bacteria that can produce a variety of toxins and is of special interest for patients with cystic fibrosis and repeated long term lung infections. The goal of this study is to determine whether specific toxins produced by Pseudomonas aeruginosa may be important in the disease process of chronic lung infections of patients with cystic fibrosis. This study will attempt to measure bacterial production of toxins in blood and sputum and immune system response to toxins in the blood....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 1998-03-17 |
| Est. Completion | 2018-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027183
The ClinicalTrials.gov registry entry for NCT00027183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00027183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027183 about?
NCT00027183 is a clinical study titled "Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa". Some bacteria that cause disease can produce toxic substances that may worsen the disease. Pseudomonas aeruginosa is a bacteria that can produce a variety of toxins and is of special interest for patients with cystic fibrosis and repeated long term lung infections. The goal of this study is to dete...
What is the current status of trial NCT00027183?
This trial is currently completed. The enrollment target is 134 participants. The study started on 1998-03-17. Estimated completion is 2018-12-28.
Who is sponsoring clinical trial NCT00027183?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.